These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 69588)

  • 21. Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants.
    Haiden N; Schwindt J; Cardona F; Berger A; Klebermass K; Wald M; Kohlhauser-Vollmuth C; Jilma B; Pollak A
    Pediatrics; 2006 Nov; 118(5):2004-13. PubMed ID: 17079573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hematologic changes in patients under long-term hemodialysis and hemofiltration treatment with special reference to serum concentrations of folic acid and vitamin B 12].
    Minar E; Zazgornik J; Bayer PM; Lanschützer H; Mengele K; Marosi L
    Schweiz Med Wochenschr; 1984 Jan; 114(2):48-53. PubMed ID: 6367027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is folate and vitamin B12 supplementation necessary in chronic hemodialysis patients with EPO treatment?
    Klemm A; Sperschneider H; Lauterbach H; Stein G
    Clin Nephrol; 1994 Nov; 42(5):343-5. PubMed ID: 7851040
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of various factors that could have an impact on the treatment with erythropoietin of hemodialysis anemia].
    Fernández-Gallego J; Ramos B; Ruiz A; Contreras J; Alvarez Bustos G; López de Novales E
    Nefrologia; 2000; 20(2):164-70. PubMed ID: 10853198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing erythropoietin hyporesponsiveness.
    Kwack C; Balakrishnan VS
    Semin Dial; 2006; 19(2):146-51. PubMed ID: 16551293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nutritional anemia].
    Horák J; Príhodová A
    Vnitr Lek; 1974 Mar; 20(3):276-86. PubMed ID: 4603715
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anemia in chronic hemodialysis; comparative value of iron therapy administered by oral and intravenous routes].
    Ducros J; Benas P; Salvadori JM; Olmer M
    J Urol Nephrol (Paris); 1977 Sep; 83(9):735-8. PubMed ID: 926237
    [No Abstract]   [Full Text] [Related]  

  • 28. Bone marrow blood formation and iron stores in patients with chronic renal failure on maintenance hemodialysis.
    Shostka GD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):769-77. PubMed ID: 6176500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosing and treating anemia and iron deficiency in hemodialysis patients.
    Foret JP
    Nephrol Nurs J; 2002 Jun; 29(3):292-6. PubMed ID: 12164080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
    Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA
    Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pregnancy anemias].
    Helbig W; Weissbach R
    Z Gesamte Inn Med; 1978 May; 33(9):285-8. PubMed ID: 676412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood folates in chronic uremic patients in dialysis treatment].
    Chelazzi G; Bernasconi G; Gastaldi L; Martegani M; Fachinetti A; Giuliani F
    Minerva Med; 1980 Oct; 71(42):3073-86. PubMed ID: 7022266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current treatment of deficiency anemias in children].
    Creţu S; Bulucea D; Ionescu D
    Rev Pediatr Obstet Ginecol Pediatr; 1977; 26(3):263-71. PubMed ID: 414327
    [No Abstract]   [Full Text] [Related]  

  • 35. Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients.
    Schiffl H; Lang SM
    Nephrol Dial Transplant; 2006 Jan; 21(1):133-7. PubMed ID: 16144854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimizing anemia in the chronic hemodialysis patient.
    Norris SH; Kurtzman NA
    Int J Artif Organs; 1986 Jul; 9(4):199-206. PubMed ID: 3781644
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral or parenteral iron therapy in haemodialysis patients?
    Winney RJ; Swainson CP; Parker AC; Bone JM; Robson JS
    Proc Eur Dial Transplant Assoc; 1977; 14():184-91. PubMed ID: 600955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Renal anemia].
    Keller P
    Med Welt; 1976 Sep; 27(38):1760-3. PubMed ID: 979598
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M; Duncan HJ; Kant KS
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
    Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.